Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma

ZHENG Ruiying; ZHANG Yi; LIU Ming; ZHANG Xiaoer; LIU Baoxian; XIE Xiaoyan; HUANG Guangliang

doi:10.19732/j.cnki.2096-6210.2026.01.002

您当前的位置：

首页 >

文章列表页 >

Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma

Specialists' Article | 更新时间：2026-03-25

- Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma
- “The quantitative parameters of contrast-enhanced ultrasound have certain value in predicting the efficacy of immunotherapy in advanced hepatocellular carcinoma, providing new ideas for precise screening of patients who benefit from treatment.”
- Oncoradiology Vol. 35, Issue 1, Pages: 10-18(2026)
- 作者机构：
  
  1.中山大学附属第一医院介入超声科，广东广州 510080
  2.中山大学附属第一医院广西医院超声医学科，广西南宁 530022
- 作者简介：
- 基金信息：
  
  National Natural Science Foundation of China(92059201);Guangxi Medical and Health Appropriate Technology Development and Application Project(S2023005);Basic and Applied Basic Research Fund of Guangdong Province(2023A1515220152)
- DOI：10.19732/j.cnki.2096-6210.2026.01.002
  CLC： R737.5;R445.1
- Received：25 November 2025，
  
  Revised：2025-12-12，
  
  Published：28 February 2026
- 稿件说明：
移动端阅览
郑瑞映, 张　艺, 刘　明, 等. 超声造影定量参数预测肝癌靶免联合治疗效果［J］. 肿瘤影像学, 2026, 35(1): 10-18.

ZHENG R　Ｙ, ZHANG Y, LIU M, et al. Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma［J］ Oncoradiology, 2026, 35(1): 10-18.
郑瑞映, 张　艺, 刘　明, 等. 超声造影定量参数预测肝癌靶免联合治疗效果［J］. 肿瘤影像学, 2026, 35(1): 10-18. DOI： 10.19732/j.cnki.2096-6210.2026.01.002.

ZHENG R　Ｙ, ZHANG Y, LIU M, et al. Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma［J］ Oncoradiology, 2026, 35(1): 10-18. DOI： 10.19732/j.cnki.2096-6210.2026.01.002.

Views

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Deep learning-based ultrasound assessment for predicting early recurrence risk after radiofrequency ablation in hepatocellular carcinoma

Nomogram prediction model of contrast-enhanced ultrasound combined with clinical and pathological features to evaluate the risk of early recurrence after surgical resection of hepatocellular carcinoma

Contrast-enhanced ultrasound for the diagnosis of intrahepatic cholangiocarcinoma: debates, focus areas and emerging perspectives

LI-RADS analysis and differential diagnosis of intrahepatic cholangiocarcinoma by contrast-enhanced ultrasound

Deep learning based on Kupffer phase of Sonazoid contrast-enhanced ultrasound to predict microvascular invasion in hepatocellular carcinoma

Related Author

ZHANG Yu

SUN Wenqi

CHEN Yuan

CHENG Wen

HAN Xue

Kunpeng CAO

Chaoli XU

Xinyue WANG

Related Institution

The department of Ultrasound, Harbin Medical University Cancer Hospital

Department of Ultrasound, The First Affiliated Hospital with Nanjing Medical University

Department of Ultrasound, Zhongshan Hospital, Fudan University

Institute of Ultrasound in Medicine and Engineering, Fudan University

Shanghai Institute of Medical Imaging

AI导读

AI脑图

AI问答

⁰

Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma

DOI：10.19732/j.cnki.2096-6210.2026.01.002